Quantile Health

251 W 30th St
New York, NY 10001

About Quantile Health

Quantile Health partners with gene therapy manufacturers to offer access to $2-5M gene therapies for a subscription fee as low as $0.03 per member per month. We completely eliminate the drug bill from impacting aggregate medical spend.

We understand that covering gene therapy can be challenging for payers. The ultra high price tag, lightning strike nature, and limited data on efficacy all pose unique challenges. Our payment model solves for these challenges - eliminating budgeting risk, linking cost to value, and providing an affordable access option for payers to ensure patient access.

Quantile Health was founded out of MIT in 2021 and is backed by MunichRe Ventures.

Competitors of Quantile Health

Medcor

Medcor

Since 1984, Medcor has provided occupational healthcare services to improve the health, safety and overall wellness of businesses across North America. We partner with businesses to conveniently meet their employee healthcare needs onsite with medical staff or remotely via telehealth. In our... Read More

UC Alternative

UC Alternative

We’re the partner that leading organizations trust to reduce unemployment costs and maximize tax savings in a complex, ever-evolving landscape. UC Alternative has been serving employers for over three decades, helping businesses spend less on unemployment claims and taxes. We were founded on a... Read More

Transition Services Inc.

Transition Services Inc.

Letting go of valued employees should never be approached from a “one size fits all” perspective. TSI’s thoughtfully designed programs ensure the smoothest possible transition for employees and employers. We offer customized Severance Management Programs, Severance Analysis & Design plans, SUB... Read More